Stephanie Hedt

Comms for @SchaefferCenter | @USCPrice & @UW grad

[Antonio Ciaccia @A_Ciaccia]

With the entire drug distribution system built to favor artificially inflated drug prices, it's no surprise that we get more and more overpriced medicines.

To eliminate these warped incentives, all drug supply chain members deserve their moment in the sun https://t.co/NQmtz2exXA

[Jessica Ellis @baddestmamajama]

Oh Buddy. You’ve done more than make them think about it. You’ve bonded them forever in a group text where one of them will share a wedding photo or promotion news and one of the others will say “i don’t know, SMELLS LIKE FAILURE.” And then they’ll all die laughing.

[Barack Obama @BarackObama]

Harry Belafonte was a barrier-breaking legend who used his platform to lift others up. He lived a good life – transforming the arts while also standing up for civil rights. And he did it all with his signature smile and style. Michelle and I send our love to his wife, kids, and fans.

[USC Schaeffer @USCSchaeffer]

Learn more: Potency caps, time-based sales limits, taxes based on potency and a seed-to-sale tracking system can provide boundaries that limit the promotion of harmful cannabis use, writes @PaculaRosalie in a Schaeffer white paper. https://t.co/Z7Sf0sveo4

[USC Schaeffer @USCSchaeffer]

New treatments for obesity are available, yet federal law constrains access to only 1% of Americans eligible for treatment. A new @USC @SchaefferCenter white paper illustrates the value of expanding coverage. @USCPrice @USCMann
https://t.co/4aGQxdwAgp

[USC Schaeffer @USCSchaeffer]

A new Schaeffer white paper finds Medicare coverage of weight loss therapies would save federal taxpayers as much as $248 billion in the first 10 years of coverage alone, if private insurers were to follow Medicare’s lead. @USCPrice @USCMann https://t.co/4aGQxdwAgp

[USC Schaeffer @USCSchaeffer]

Treatments targeting obesity are available, but Medicare and private insurers cover few, leaving many patients without options. Join us and @BPC_Bipartisan next Tuesday for a policy discussion focused on increasing access to treatment https://t.co/Hk1oE3MFmK

[USC Schaeffer @USCSchaeffer]

Schaeffer Center Co-Director and @USCMann Prof Erin Trish testified in front of the @commercedems last week, noting opaque pricing by PBMs creates mystery in the drug distribution system, “and where there is mystery, there is margin.” @USCPrice https://t.co/BGmoiWV2Vj

[USC Schaeffer @USCSchaeffer]

Clinicians who received a letter from their county's medical examiner notifying them of a patient's fatal overdose wrote 7% fewer prescriptions one year later. Schaeffer expert & @USCPrice prof @jasndoc led the study published today in @JAMANetworkOpen https://t.co/aQI8dOXF4P

[USC Schaeffer @USCSchaeffer]

The list price of insulin more than doubled between 2012 and 2019. Yet how we got here – and who is responsible for the rising prices – is complicated. Neeraj Sood and @KarenVanNuys shared 5 takeaways from their research with @uscprice https://t.co/iXxDVsihY5

[Keck School of Medicine of USC @KECKSchool_USC]

So far, this year’s flu season is on track to be one of the most severe in more than a decade. There are also concerns of a potential #tripledemic, with the flu, RSV and COVID-19 circulating widely. Get your #FluShot today!

#NationalInfluenzaVaccinationWeek

[USC Schaeffer @USCSchaeffer]

What's left out of the insulin price discussion? "Middlemen are making more and more money," @USCPrice Schaeffer Center Senior Fellow Neeraj Sood told the @WSJ. https://t.co/qTfYqbwiPB

[USC Schaeffer @USCSchaeffer]

Today, more than 4 in 10 U.S. adults have obesity. @BPC_Bipartisan's @AParekhBPC and @SchaefferCenter @USCPrice's Dana Goldman discuss what Congress can do to ensure access to treatment: https://t.co/uP1KIOShKt

[USC Schaeffer @USCSchaeffer]

According to research by @KarenVanNuys, while insulin manufacturers are making less, patients are not seeing the savings because intermediaries are making more. Find out more at the link below. #WorldDiabetesDay https://t.co/260Wsqtet0

[Bipartisan Policy Center @BPC_Bipartisan]

#DYK that those with obesity are more likely to experience Type 2 diabetes, high blood pressure, and high cholesterol?

On this #WorldDiabetesDay, find out more about how greater access to obesity treatments could help. https://t.co/sWkpQ2G72n

[USC Schaeffer @USCSchaeffer]

Want to learn about whether dialysis facilities owned by kidney docs provide better care? @eugelin06 explains his latest research:

[USC Schaeffer @USCSchaeffer]

Schaeffer expert and Nobel laureate Daniel McFadden has researched why most beneficiaries don't switch Part D plans, even though many could save money. https://t.co/bCqWUmdq8G

[Stephanie Hedt @StephanieHedt]

@LichtmanRachel @USCPrice @studenthealthsc Congrats, Rachel!

[USC Schaeffer @USCSchaeffer]

Congratulations to Schaeffer Senior Fellow and @USC @USCPrice Prof Paul Ginsburg who was elected to @theNAMedicine for his role in shaping U.S. health policy https://t.co/NnhgWlufMP

[L.A. Public Library @LAPublicLibrary]

As an update, books are still working.

https://t.co/IwJyCZfUKx